Skip to content

ML-Based Multi-Sensor Fall Risk Screening in DMD

Quantitative Analysis of Upper Extremity Functional Movement of the Upper Extremity in Patients With Duchenne Muscular Dystrophy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07015632
Enrollment
30
Registered
2025-06-11
Start date
2024-07-18
Completion date
2026-12-01
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DMD

Brief summary

This prospective observational study aims to analyze changes in upper extremity functional movement over time in children with Duchenne Muscular Dystrophy (DMD). Thirty patients will be evaluated at three time points (baseline, 6 months, 12 months) using clinical assessments (PUL 2.0, Brooke Scale, grip strength), computer vision-based video analysis, and machine learning algorithms. The goal is to improve future upper limb evaluation methods for non-ambulatory DMD patients. The study includes safety monitoring and adheres to ethical standards, ensuring patient data confidentiality and providing compensation if adverse effects occur.

Interventions

OTHERPerformance of the Upper Limb, Brooke Scale, grip strength test

Thirty patients will be evaluated at three time points (baseline, 6 months, 12 months) using clinical assessments (PUL 2.0, Brooke Scale, grip strength), computer vision-based video analysis, and machine learning algorithms.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

1. Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy (DMD) 2. Age over 10 and under 30 years 3. Brooke Scale score between 2 and 5 4. Manual muscle test grade below 3 for shoulder abduction muscles

Exclusion criteria

1. Individuals who are unable or unwilling to provide informed consent 2. Brooke Scale score of 1 or 6 3. Individuals with cognitive impairments that significantly limit their ability to participate in assessments

Design outcomes

Primary

MeasureTime frameDescription
Performance of the upper limb module 2.0baseline - 6 months - 12 monthsThe Performance of the Upper Limb (PUL) Module 2.0 is a validated assessment tool designed to evaluate upper limb function in individuals with Duchenne Muscular Dystrophy. The PUL 2.0 consists of 22 items covering three domains: shoulder level, mid-level (elbow), and distal level (hand). Each item is scored based on task performance, and the total score ranges from 0 to 42, with higher scores indicating better upper limb function.

Secondary

MeasureTime frameDescription
Brooke scorebaseline - 6 months - 12 monthsThe Brooke Upper Extremity Functional Rating Scale is a 6-point scale used to evaluate upper limb functional ability, primarily in patients with neuromuscular disorders such as Duchenne Muscular Dystrophy. Scores range from 1 to 6, where: 1 = Able to abduct arms in a full circle until they touch above the head 6 = Cannot raise hands to the mouth and has no useful function of the hands Lower scores indicate better upper limb function.
grip strengthbaseline - 6 months - 12 monthsGrip strength will be measured using the Jamar Plus+ Digital Hand Dynamometer, a validated and widely used device for quantifying hand grip strength in kilograms (kg). Participants will be instructed to sit upright with the shoulder adducted and neutrally rotated, elbow flexed at 90 degrees, forearm in neutral position, and wrist in 0 to 30 degrees extension. The average of three consecutive trials will be recorded for each assessment. Higher values indicate greater grip strength.

Countries

South Korea

Contacts

Primary ContactJungHyun Kim, prof
kiking0@naver.com82+1088632341

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026